Medicis Pharmaceutical Corp. (MRX) Tops Q4 EPS by 14c
Tweet
Share
E-mailGet Alerts MRX Hot Sheet
Price: $72.62 +0.19%
EPS Growth %: +27.1%
Financial Fact:
Income from continuing operations before income tax expense: 1.82M
Today's EPS Names:
PMCB, PLCE, DOMO, More
EPS Growth %: +27.1%
Financial Fact:
Income from continuing operations before income tax expense: 1.82M
Today's EPS Names:
PMCB, PLCE, DOMO, More
Join SI Premium – FREE
Medicis Pharmaceutical Corp. (NASDAQ: MRX) reported Q4 EPS of $1.13, $0.14 better than the analyst estimate of $0.99. Revenue for the quarter came in at $572.1 million versus the consensus estimate of $508.62 million.
For earnings history and earnings-related data on Medicis Pharmaceutical Corp. (MRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- NIO Inc. (NIO) Tops Q2 EPS by 33c; offers guidance
- Medtronic jumps on earnings beat and raised guidance
- Palo Alto Networks (PANW) Tops Q4 EPS by 4c, Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
